ChemFeeds Site Navigation:
Journal Selection:
Search:

99) Nilotinib in Previously Treated KIT-Altered Melanoma (Clinical Cancer Research) Friday May 15th 2015


100) NFAT-IL12 in TIL Trial (Clinical Cancer Research) Friday May 15th 2015


101) MAGE-A4 TCR-Transduced T-cell Transfer for Esophageal Cancer (Clinical Cancer Research) Friday May 15th 2015


102) Accelerating the Delivery of Patient-Centered, High-Quality Cancer Care (Clinical Cancer Research) Friday May 15th 2015


103) Immune Checkpoint Modulation for Non-Small Cell Lung Cancer (Clinical Cancer Research) Friday May 15th 2015


104) Recent Progress in SCLC May Lead to Improved Outcomes (Clinical Cancer Research) Friday May 15th 2015


105) Squamous Cell Lung Cancer (Clinical Cancer Research) Friday May 15th 2015


106) ALK in Cancer (Clinical Cancer Research) Friday May 15th 2015


107) EGFR as Paradigm of an Oncogene-Driven Lung Cancer (Clinical Cancer Research) Friday May 15th 2015


108) Integrating Lung Cancer Genomics and Therapeutics (Clinical Cancer Research) Friday May 15th 2015


109) Quit Early, Quit Often (Clinical Cancer Research) Friday May 15th 2015


110) Inducible Drug Glucuronidation (Clinical Cancer Research) Friday May 15th 2015


111) Molecular Classification of Diffuse Large B-cell Lymphoma (Clinical Cancer Research) Friday May 15th 2015


112) HHLA2: A New Target for Cancer Immunotherapy (Clinical Cancer Research) Friday May 15th 2015


113) Vorinostat: Gateway to Epigenetic Therapy (Clinical Cancer Research) Friday May 15th 2015


114) Expanding the Epigenetic Portfolio (Clinical Cancer Research) Friday May 15th 2015


115) Correction: Phase I Safety, Pharmacokinetic, and Pharmacodynamic Study of SAR245408 (XL147), an Oral Pan-Class I PI3K Inhibitor, in Patients with Advanced Solid Tumors (Clinical Cancer Research) Thursday April 30th 2015


116) Correction: Associations and Interactions between Ets-1 and Ets-2 and Coregulatory Proteins, SRC-1, AIB1, and NCoR in Breast Cancer (Clinical Cancer Research) Thursday April 30th 2015


117) Retraction: Glioma-Associated Cancer-Initiating Cells Induce Immunosuppression (Clinical Cancer Research) Thursday April 30th 2015


118) RAF plus EGFR Inhibition for BRAF-Mutant Metastatic Colorectal Cancer--Response (Clinical Cancer Research) Thursday April 30th 2015


119) RAF plus EGFR Inhibition for BRAF-Mutant Metastatic Colorectal Cancer--Letter (Clinical Cancer Research) Thursday April 30th 2015


120) MiHA Identification by Reverse Immunology (Clinical Cancer Research) Thursday April 30th 2015


121) ITK, a Therapeutic Target in Melanoma (Clinical Cancer Research) Thursday April 30th 2015


122) EGFR Mutations and Resistance to Cetuximab (Clinical Cancer Research) Thursday April 30th 2015


123) Impact of Clone Size on FISH in Myeloma (Clinical Cancer Research) Thursday April 30th 2015


124) Role of PLEKHA5 in Melanoma Brain Metastasis (Clinical Cancer Research) Thursday April 30th 2015


125) Inhibition of Angiogenesis by Zoledronic Acid (Clinical Cancer Research) Thursday April 30th 2015


126) Targeted Therapy in CLL (Clinical Cancer Research) Thursday April 30th 2015


127) Chemotherapy Contributes to Drug Resistance (Clinical Cancer Research) Thursday April 30th 2015


128) Pralatrexate and Romidepsin in Preclinical T-cell Lymphoma (Clinical Cancer Research) Thursday April 30th 2015


129) Antitumor Effect of Notch2/3 Antagonist (Tarextumab) (Clinical Cancer Research) Thursday April 30th 2015


130) "Don't Eat Me" aAPC for Enhanced In Vivo Function (Clinical Cancer Research) Thursday April 30th 2015


131) PTEN Status and Clinical Outcome in Breast Cancer (Clinical Cancer Research) Thursday April 30th 2015


132) DIRECTOR Trial for Recurrent Glioblastoma (Clinical Cancer Research) Thursday April 30th 2015


133) Genomic Complexity, Gene Mutations, and Outcomes in AML (Clinical Cancer Research) Thursday April 30th 2015


134) MIR27A Polymorphisms and Fluoropyrimidine Toxicity (Clinical Cancer Research) Thursday April 30th 2015


135) The Individualized Molecular Pancreatic Cancer Therapy Trial (Clinical Cancer Research) Thursday April 30th 2015


136) Impact of cGVHD on Late Relapse and Survival (Clinical Cancer Research) Thursday April 30th 2015


137) Genomics of HPV-Associated Cancers (Clinical Cancer Research) Thursday April 30th 2015


138) State of the Art: MRD Testing for Myeloma (Clinical Cancer Research) Thursday April 30th 2015


139) Improving Radiotherapy via Modification of Oxygenation (Clinical Cancer Research) Thursday April 30th 2015


140) Targeting NRG1 Fusions (Clinical Cancer Research) Thursday April 30th 2015


141) Exploiting the New Biology of Glioblastoma (Clinical Cancer Research) Thursday April 30th 2015


142) Chronic GVHD and Leukemia Relapse (Clinical Cancer Research) Thursday April 30th 2015


143) Role of PLEKHA5 in CNS Homing (Clinical Cancer Research) Thursday April 30th 2015


144) Nab-Paclitaxel: How Far Science Has Come (Clinical Cancer Research) Thursday April 30th 2015


145) Chemoresistance in Fanconi Anemia Head and Neck Cancers (Clinical Cancer Research) Wednesday April 15th 2015


146) Implications for Tumor Classifications and Targeted Therapies (Clinical Cancer Research) Wednesday April 15th 2015


147) Very Long-term Survival in Pancreatic Cancer (Clinical Cancer Research) Wednesday April 15th 2015


148) MEK1 Mutations in Lung Carcinoma (Clinical Cancer Research) Wednesday April 15th 2015


149) S1P Inhibition as a New Treatment for RCC (Clinical Cancer Research) Wednesday April 15th 2015


150) Efficacy of MK-1775 in PDX Models of GBM (Clinical Cancer Research) Wednesday April 15th 2015


151) Gene Expression-Based Risk Stratification of Neuroblastoma (Clinical Cancer Research) Wednesday April 15th 2015


152) Bevacizumab in NSCLC Patients with Asymptomatic Brain Metastases (Clinical Cancer Research) Wednesday April 15th 2015


153) First-in-Human Study of PF-05212384 in Advanced Cancers (Clinical Cancer Research) Wednesday April 15th 2015


154) Impact of Coffee on Breast Cancer (Clinical Cancer Research) Wednesday April 15th 2015


155) Infections and PI3K-AKT-mTOR Inhibitors (Clinical Cancer Research) Wednesday April 15th 2015


156) Biologic Activity of Everolimus in Resectable Lung Cancer (Clinical Cancer Research) Wednesday April 15th 2015


157) Bevacizumab Preconditioned Regimen in Brain Metastases (Clinical Cancer Research) Wednesday April 15th 2015


158) JNJ-40346527 for Relapsed or Refractory Hodgkin Lymphoma (Clinical Cancer Research) Wednesday April 15th 2015


159) Lenalidomide-Rituximab for Rituximab-Resistant Lymphoma (Clinical Cancer Research) Wednesday April 15th 2015


160) Ras and Cancer Metabolism (Clinical Cancer Research) Wednesday April 15th 2015


161) Targeting RAS Membrane Interactions (Clinical Cancer Research) Wednesday April 15th 2015


162) Direct Attack on RAS (Clinical Cancer Research) Wednesday April 15th 2015


163) RAS Synthetic Lethal Screens Revisited (Clinical Cancer Research) Wednesday April 15th 2015


164) KRAS as a Therapeutic Target (Clinical Cancer Research) Wednesday April 15th 2015


165) Targeting RAS: The Elusive Prize (Clinical Cancer Research) Wednesday April 15th 2015


166) Cbl Proteins and Cancer (Clinical Cancer Research) Wednesday April 15th 2015


167) Heterogeneity in Liver Cancer (Clinical Cancer Research) Wednesday April 15th 2015


168) Predicting the Future in Neuroblastoma (Clinical Cancer Research) Wednesday April 15th 2015


169) The Development of Breast Cancer Molecular Subtyping (Clinical Cancer Research) Wednesday April 15th 2015


170) Correction: Combining PCI-24781, a Novel Histone Deacetylase Inhibitor, with Chemotherapy for the Treatment of Soft Tissue Sarcoma (Clinical Cancer Research) Tuesday March 31st 2015


171) Correction: TRAIL and Doxorubicin Combination Induces Proapoptotic and Antiangiogenic Effects in Soft Tissue Sarcoma In Vivo (Clinical Cancer Research) Tuesday March 31st 2015


172) Correction: Molecular Pathways: Targeting the Kinase Effectors of RHO-Family GTPases (Clinical Cancer Research) Tuesday March 31st 2015


173) Plasma Biomarkers for Early Diagnosis of Pancreas Cancer (Clinical Cancer Research) Tuesday March 31st 2015


174) BATF2 Deficiency in Colorectal Cancer Provides a New Therapeutic Strategy (Clinical Cancer Research) Tuesday March 31st 2015


175) EcSOD and Pancreatic Cancer Progression (Clinical Cancer Research) Tuesday March 31st 2015


176) Myofibrillar Protein Synthesis in Cancer Cachexia (Clinical Cancer Research) Tuesday March 31st 2015


177) Pancreatic Cancer Exosomes Cause Paraneoplastic Diabetes (Clinical Cancer Research) Tuesday March 31st 2015


178) Antigen Expression and -Specific T-cell Responses in Myeloma (Clinical Cancer Research) Tuesday March 31st 2015


179) Global Methylation Analysis in Natural Killer Cell Lymphoma (Clinical Cancer Research) Tuesday March 31st 2015


180) Identification of Four Unique Subtypes of TNBCs (Clinical Cancer Research) Tuesday March 31st 2015


181) Targeting AR in ENZ-R Prostate Cancer Cells (Clinical Cancer Research) Tuesday March 31st 2015


182) A Novel Oncolytic Adenovirus for Pancreatic Cancer (Clinical Cancer Research) Tuesday March 31st 2015


183) Macrophages Confer BRAF Inhibitor Resistance (Clinical Cancer Research) Tuesday March 31st 2015


184) Dabrafenib and Trametinib Effect on Immune Function (Clinical Cancer Research) Tuesday March 31st 2015


185) OTX015 in Preclinical Models of Lymphomas (Clinical Cancer Research) Tuesday March 31st 2015


186) Radiographic Progression-Free Survival by ERG Gene Status (Clinical Cancer Research) Tuesday March 31st 2015


187) DNMT3A Affects Response to Dose-Escalated AML Induction Therapy (Clinical Cancer Research) Tuesday March 31st 2015


188) miR-499 Genetic Variants and Lung Cancer Prognosis (Clinical Cancer Research) Tuesday March 31st 2015


189) KEAP1 Genetic Polymorphism Predicts Outcome in Breast Cancer (Clinical Cancer Research) Tuesday March 31st 2015


190) Phase III Intergroup 0144 Trial's Pharmacogenetic Analysis (Clinical Cancer Research) Tuesday March 31st 2015


191) Cyclophosphamide and Veliparib in BRCA+ Ovarian Cancer (Clinical Cancer Research) Tuesday March 31st 2015


192) CUDC-101 plus Cisplatin-Radiotherapy for HNSCC (Clinical Cancer Research) Tuesday March 31st 2015


193) Pediatric Phase I Trial of Cixutumumab and Temsirolimus (Clinical Cancer Research) Tuesday March 31st 2015


194) Self-Antigens and Inflammatory Signals in Cancer Prevention (Clinical Cancer Research) Tuesday March 31st 2015


195) Aspirin and Wnt Signaling (Clinical Cancer Research) Tuesday March 31st 2015


196) Idelalisib: PI3K Delta Inhibitor (Clinical Cancer Research) Tuesday March 31st 2015


View: prev | next


Mitch Andre Garcia's Chem Feeds 2008-present

Some images have been reproduced by permission of The Royal Society of Chemistry. (RSC' RSS Policy)
Other images have been reproduced with permission of the American Chemical Society. (ACS' RSS Policy)
Few images have been reproduced with pending permission of Wiley-VCH. ()